<VariationArchive VariationID="2579187" VariationName="GRCh38/hg38 2q31.2(chr2:178553579-178637393)x1" VariationType="copy number loss" Accession="VCV002579187" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2023-09-16" MostRecentSubmission="2023-09-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2744225" VariationID="2579187">
      <GeneList>
        <Gene Symbol="LOC126806422" FullName="BRD4-independent group 4 enhancer GRCh37_chr2:179440205-179441404" GeneID="126806422" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="178575478" stop="178576677" display_start="178575478" display_stop="178576677" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC126806423" FullName="CDK7 strongly-dependent group 2 enhancer GRCh37_chr2:179443309-179444508" GeneID="126806423" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="178578582" stop="178579781" display_start="178578582" display_stop="178579781" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC126806424" FullName="CDK7 strongly-dependent group 2 enhancer GRCh37_chr2:179456337-179457536" GeneID="126806424" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="178591610" stop="178592809" display_start="178591610" display_stop="178592809" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC126806425" FullName="BRD4-independent group 4 enhancer GRCh37_chr2:179471933-179473132" GeneID="126806425" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="178607206" stop="178608405" display_start="178607206" display_stop="178608405" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC126806426" FullName="BRD4-independent group 4 enhancer GRCh37_chr2:179478848-179480047" GeneID="126806426" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="178614121" stop="178615320" display_start="178614121" display_stop="178615320" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC126806427" FullName="BRD4-independent group 4 enhancer GRCh37_chr2:179485777-179486976" GeneID="126806427" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="178621050" stop="178622249" display_start="178621050" display_stop="178622249" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129388955" FullName="MPRA-validated peak3948 silencer" GeneID="129388955" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="178627328" stop="178627528" display_start="178627328" display_stop="178627528" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="TTN" FullName="titin" GeneID="7273" HGNC_ID="HGNC:12403" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="178525989" stop="178807423" display_start="178525989" display_stop="178807423" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="179390715" stop="179672149" display_start="179390715" display_stop="179672149" Strand="-" />
          </Location>
          <OMIM>188840</OMIM>
          <Haploinsufficiency last_evaluated="2021-08-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TTN">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-08-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TTN">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
        <Gene Symbol="TTN-AS1" FullName="TTN antisense RNA 1" GeneID="100506866" HGNC_ID="HGNC:44124" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="178522827" stop="178620217" display_start="178522827" display_stop="178620217" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>GRCh38/hg38 2q31.2(chr2:178553579-178637393)x1</Name>
      <VariantType>copy number loss</VariantType>
      <Location>
        <CytogeneticLocation>2q31.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="178553579" stop="178637393" display_start="178553579" display_stop="178637393" variantLength="83815" />
      </Location>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="GRCh38/hg38 2q31.2(chr2:178553579-178637393)x1 AND Dilated cardiomyopathy 1G" Accession="RCV003327626" Version="3">
        <ClassifiedConditionList TraitSetID="3438">
          <ClassifiedCondition DB="MedGen" ID="C1858763">Dilated cardiomyopathy 1G</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-09-16" MostRecentSubmission="2023-09-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">31690835</ID>
          <ID Source="pmc">7313390</ID>
          <ID Source="DOI">10.1038/s41436-019-0686-8</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34740920</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3438" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1308" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dilated cardiomyopathy 1G</ElementValue>
                <XRef ID="MONDO:0011400" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMD1G</ElementValue>
                <XRef Type="MIM" ID="604145" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15363" />
                <XRef ID="15363" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301486</ID>
                <ID Source="BookShelf">NBK1309</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="154" DB="Orphanet" />
              <XRef ID="C1858763" DB="MedGen" />
              <XRef ID="MONDO:0011400" DB="MONDO" />
              <XRef Type="MIM" ID="604145" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7549696" SubmissionDate="2023-09-11" DateLastUpdated="2023-09-16" DateCreated="2023-09-16">
        <ClinVarSubmissionID localKey="VCGS_FAM71|OMIM:604145|copy:1|refcopy:2" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004034277" DateUpdated="2023-09-16" DateCreated="2023-09-16" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31690835</ID>
          </Citation>
          <Comment>A confirmed de novo heterozygous deletion of exons 225-334 in TTN (NM_001267550.2) was identified by exome sequencing and confirmed by targeted chromosomal microarray of the TTN gene in one individual with dilated cardiomyopathy ([GRCh38] chr2:178553579_178637393x1)(PMID: 34740920). The patient phenotype is nonspecific, but is consistent with cases described in the literature and/or published databases with overlapping variants. This intragenic variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at exon 3 and leads to a premature termination codon. This alteration is then predicted to lead to a truncated or absent. The TTN gene is known to be haploinsufficient, and has been assessed by the ClinGen Dosage Sensitivity Working Group (https://search.clinicalgenome.org/kb/gene-dosage). In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant dilated cardiomyopathy. The ACMG/ClinGen evidence codes and points used in this curation are as follows: 1: 0 points, 2: 0.90 points, 3: 0 points, 4-5: 0.15 points; Total: 1.05 points; Riggs 2020 (PMID: 31690835).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG/ClinGen CNV Guidelines, 2019</Attribute>
          <Citation>
            <ID Source="PubMed">31690835</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <Citation>
              <ID Source="PubMed">34740920</ID>
            </Citation>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TTN" />
          </GeneList>
          <VariantType>copy number loss</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="2" start="178553579" stop="178637393" variantLength="83815" />
          </Location>
          <AttributeSet>
            <Attribute Type="AbsoluteCopyNumber">1</Attribute>
          </AttributeSet>
          <AttributeSet>
            <Attribute Type="ReferenceCopyNumber">2</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604145" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13816677</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7549696" TraitType="Disease" MappingType="XRef" MappingValue="604145" MappingRef="OMIM">
        <MedGen CUI="C1858763" Name="Dilated cardiomyopathy 1G" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

